{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:42:55Z","timestamp":1790757775222,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Multiple Sclerosis Society of the Great Britain"},{"name":"University Hospital Nottingham"},{"DOI":"10.13039\/501100000837","name":"The University of Nottingham","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.imbio.2020.152023","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T01:18:06Z","timestamp":1605230286000},"page":"152023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["PAF-R on activated T cells: Role in the IL-23\/Th17 pathway and relevance to multiple sclerosis"],"prefix":"10.1016","volume":"226","author":[{"given":"Angela","family":"Midgley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjit","family":"Braitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calen","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihailo","family":"Nebozhyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Adrian","family":"Robins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Showe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris S.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2020.152023_b0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2020.152023_b0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2020.152023_b0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1871527315666160615110739","article-title":"Assessment of interleukin-17A, interleukin-10 and transforming growth factor-beta1 serum titers in relapsing remitting multiple sclerosis patients treated with avonex, possible biomarkers for treatment response","volume":"16","author":"Balasa","year":"2017","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.imbio.2020.152023_b0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1523\/JNEUROSCI.1171-15.2016","article-title":"Platelet-activating factor receptors mediate excitatory postsynaptic hippocampal injury in experimental autoimmune encephalomyelitis","volume":"36","author":"Bellizzi","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imbio.2020.152023_b0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2020.152023_b0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/jnnp.58.3.360","article-title":"Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis","volume":"58","author":"Brochet","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.imbio.2020.152023_b0035","doi-asserted-by":"crossref","first-page":"e13032","DOI":"10.1111\/eci.13032","article-title":"Functional and phenotypic heterogeneity of Th17 cells in health and disease","volume":"49","author":"Bystrom","year":"2019","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.imbio.2020.152023_b0040","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/eji.1830220604","article-title":"Induction of high-affinity paf receptor expression during T cell activation","volume":"22","author":"Calabresse","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2020.152023_b0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0165-5728(98)00246-X","article-title":"Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis","volume":"94","author":"Callea","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2020.152023_b0050","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0022-5347(25)00235-6","article-title":"Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor [published correction appears in J Pharmacol Exp Ther 1988; 245 749]","volume":"241","author":"Casals-Stenzel","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.imbio.2020.152023_b0055","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.3390\/molecules16097634","article-title":"A novel anti-inflammatory role for ginkgolide B in asthma via inhibition of the ERK\/MAPK signaling pathway","volume":"16","author":"Chu","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.imbio.2020.152023_b0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/2319-4170.128746","article-title":"The essential role of T cells in multiple sclerosis: a reappraisal","volume":"37","author":"Constantinescu","year":"2014","journal-title":"Biomed. J."},{"key":"10.1016\/j.imbio.2020.152023_b0065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imbio.2020.152023_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/913802","article-title":"Platelet-activating factor induces Th17 cell differentiation","volume":"2011","author":"Drolet","year":"2011","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.imbio.2020.152023_b0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1191\/1352458504ms1087oa","article-title":"A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic","volume":"10","author":"Edwards","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.imbio.2020.152023_b0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/187152809788681010","article-title":"Platelet activating factor\/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases","volume":"8","author":"Edwards","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.imbio.2020.152023_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cyto.2009.12.003","article-title":"Th17\/Th1 phenotype in demyelinating disease","volume":"50","author":"Edwards","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.imbio.2020.152023_b0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2006.10.002","article-title":"Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs","volume":"182","author":"El Behi","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2020.152023_b0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1189\/jlb.0605296","article-title":"Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent","volume":"80","author":"Fahey","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imbio.2020.152023_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0143-4160(03)00170-2","article-title":"Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1","volume":"35","author":"Fox","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.imbio.2020.152023_b0105","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2020.152023_b0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13578-019-0316-9","article-title":"Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2","volume":"9","author":"Hamel-Cote","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.imbio.2020.152023_b0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1476-5381.1989.tb11939.x","article-title":"Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonists","volume":"197","author":"Hellewell","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imbio.2020.152023_b0120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/eji.200535239","article-title":"Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells","volume":"36","author":"Hoeve","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2020.152023_b0125","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/oxfordjournals.jbchem.a003164","article-title":"Platelet-activating factor receptor","volume":"131","author":"Honda","year":"2002","journal-title":"J. Biochem."},{"key":"10.1016\/j.imbio.2020.152023_b0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF01972856","article-title":"An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats","volume":"27","author":"Howat","year":"1989","journal-title":"Agents Actions"},{"key":"10.1016\/j.imbio.2020.152023_b0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10753-007-9056-9","article-title":"Platelet activating factor as a mediator and therapeutic approach in bronchial asthma","volume":"31","author":"Kasperska-Zajac","year":"2008","journal-title":"Inflammation"},{"key":"10.1016\/j.imbio.2020.152023_b0140","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.imbio.2011.07.018","article-title":"IL-12 inhibits glucocorticoid-induced T cell apoptosis by inducing GMEB1 and activating PI3K\/Akt pathway","volume":"217","author":"Kawabe","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2020.152023_b0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-030-21735-8_13","article-title":"Systematic understanding of bioactive lipids in neuro-immune interactions: lessons from an animal model of multiple sclerosis","volume":"1161","author":"Kihara","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.imbio.2020.152023_b0150","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.imbio.2020.152023_b0155","doi-asserted-by":"crossref","first-page":"L75","DOI":"10.1152\/ajplung.2000.279.1.L75","article-title":"Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally","volume":"279","author":"Lee","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.imbio.2020.152023_b0160","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2020.152023_b0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007806","article-title":"Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study","volume":"5","author":"Manouchehrinia","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.imbio.2020.152023_b0170","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20050665","article-title":"Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis","volume":"202","author":"Marusic","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2020.152023_b0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2008.08.012","article-title":"Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses","volume":"204","author":"Marusic","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2020.152023_b0180","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2020.152023_b0185","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1038\/s41598-018-26519-w","article-title":"Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients","volume":"8","author":"Montes Diaz","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2020.152023_b0190","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ni0608-588","article-title":"Differentiation of human T(H)-17 cells does require TGF-beta!","volume":"9","author":"O'Garra","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2020.152023_b0195","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1073\/pnas.252777399","article-title":"Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination","volume":"100","author":"Pedotti","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2020.152023_b0200","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4049\/jimmunol.153.1.364","article-title":"Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma","volume":"153","author":"Simon","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2020.152023_b0205","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ajpath.2010.10.008","article-title":"Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-beta1 transgenic mice","volume":"178","author":"Singh","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imbio.2020.152023_b0210","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/ane.12715","article-title":"Decreased interferon-\u03b2 induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis","volume":"136","author":"Tanasescu","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.imbio.2020.152023_b0215","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2020.152023_b0220","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/0024-3205(83)90049-8","article-title":"CV-3988 - a specific antagonist of platelet activating factor (PAF)","volume":"32","author":"Terashita","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.imbio.2020.152023_b0225","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/intimm\/2.6.545","article-title":"Immunoregulatory functions of paf-acether. VI. Inhibition of T cell activation via CD3 and potentiation of T cell activation via CD2","volume":"2","author":"Vivier","year":"1990","journal-title":"Int. Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520305453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520305453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:47:08Z","timestamp":1759250828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298520305453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0171298520305453"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2020.152023","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAF-R on activated T cells: Role in the IL-23\/Th17 pathway and relevance to multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2020.152023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152023"}}